Methylenetetrahydrofolate reductase C677T polymorphism and Factor V Leiden variant in Mexican women with preeclampsia/eclampsia
- 31 August 2005
- journal article
- Published by Elsevier BV in Blood Cells, Molecules, and Diseases
- Vol. 35 (1), 66-69
- https://doi.org/10.1016/j.bcmd.2005.03.008
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Factor V Leiden, prothrombin 20210G → A, methylenetetrahydrofolate reductase 677C → T and plasminogen activator inhibitor 4G/5G polymorphism in women with pregnancy-related venous thromboembolismEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 2003
- Contemporary Concepts of the Pathogenesis and Management of PreeclampsiaJAMA, 2002
- The methylenetetrahydrofolate reductase 677 C→T polymorphism and preeclampsia in two populationsPublished by Ovid Technologies (Wolters Kluwer Health) ,2002
- 677 C→T polymorphism of the methylenetetrahydrofolate reductase gene and preeclampsiaPublished by Ovid Technologies (Wolters Kluwer Health) ,2000
- Severe preeclampsia and high frequency of genetic thrombophilic mutationsPublished by Ovid Technologies (Wolters Kluwer Health) ,2000
- The C677T polymorphism of the methylenetetrahydrofolate reductase gene in Mexican mestizo neural-tube defect parents, control mestizo and native populationsAnnales de Genetique, 2000
- Increased Frequency of Genetic Thrombophilia in Women with Complications of PregnancyNew England Journal of Medicine, 1999
- Methylenetetrahydrofolate reductase polymorphism and pre-eclampsia.Journal of Medical Genetics, 1997
- The factor V Leiden mutation may predispose women to severe preeclampsiaAmerican Journal of Obstetrics and Gynecology, 1996
- Hyperhomocysteinaemia and recurrent spontaneous abortion or abruptio placentaeThe Lancet, 1992